ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

161 hedge funds and large institutions have $770M invested in Achillion Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$125M
Puts
$39.3M
Net Calls
Net Calls Change

Top Buyers

1 +$36M
2 +$27.5M
3 +$12.4M
4
Goldman Sachs
Goldman Sachs
New York
+$9.47M
5
Millennium Management
Millennium Management
New York
+$9.33M

Top Sellers

1 -$158M
2 -$48.8M
3 -$25.4M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$7.78M
5
Morgan Stanley
Morgan Stanley
New York
-$7.72M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$188K
127
$182K
128
$174K
129
$168K
130
$167K
131
$159K
132
$156K
133
$147K
134
$136K
135
$134K
136
$130K
137
$130K
138
$120K
139
$119K
140
$110K
141
$110K
142
$108K
143
$104K
144
$101K
145
$94.2K
146
$70K
147
$60K
148
$59K
149
$54K
150
$53K